Meeder Advisory Services’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$176K Sell
12,990
-4,240
-25% -$50.7K 0.01% 719
2026
Q1
$103K Sell
17,230
-30,410
-64% -$229K ﹤0.01% 680
2025
Q4
$342K Sell
47,640
-20,280
-30% -$160K 0.01% 482
2025
Q3
$725K Buy
67,920
+32,205
+90% +$316K 0.03% 326
2025
Q2
$346K Buy
35,715
+10,282
+40% +$106K 0.02% 451
2025
Q1
$379K Buy
25,433
+6,122
+32% +$94.1K 0.02% 410
2024
Q4
$288K Buy
19,311
+8,970
+87% +$146K 0.02% 462
2024
Q3
$198K Sell
10,341
-523
-5% -$10.8K 0.01% 531
2024
Q2
$225K Buy
+10,864
New +$216K 0.02% 467

Other funds holding OGN

Meeder Advisory Services's OGN Position: Q2 2026 in Review

Meeder Advisory Services reduced its Organon & Co (OGN) stake by 25% in Q2 2026, selling an estimated $50.7K and leaving 12,990 shares worth $176K. The position accounts for 0.01% of the portfolio, ranked #719.

Meeder Advisory Services first reported a position in OGN in Q2 2024 and has held it in 9 quarters since. The position peaked at $725K in Q3 2025. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Meeder Advisory Services held 12,990 shares of Organon & Co worth $176K as of Q2 2026.
  • Meeder Advisory Services sold 4,240 Organon & Co shares in Q2 2026, an estimated $50.7K.
  • Organon & Co made up 0.01% of Meeder Advisory Services's portfolio in Q2 2026, its #719 holding.
  • Meeder Advisory Services first reported a position in Organon & Co in Q2 2024 and has held it in 9 quarters since.
  • Meeder Advisory Services's Organon & Co position peaked at $725K in Q3 2025.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Meeder Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.